Clinical Trials Sponsored by The First Hospital of Xiaoshan District, Hangzhou

Total 947 results

Second Affiliated Hospital, School of Medicine,...
First People's Hospital of Hangzhou; Ningbo Medical Center Lihuili Hospital; Sir... and other collaborators

Not yet recruiting

Cross-sectional Survey of Zhejiang ECMO Application

Extracorporeal Membrane Oxygenation | Cardiopulmonary Resuscitation | Epidemiology

China
First People's Hospital of Hangzhou
Hangzhou Cancer Hospital; First People's Hospital of Lin'an District; First People...

Recruiting

Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients

Hospitalized Patients

China
The First People's Hospital of Yuhang District

Completed

Gastric Outlet Obstructions Tailored Covered Stents for GOO

Gastric Outlet Obstruction

China
The First People's Hospital of Changzhou

Not yet recruiting

SBRT Combined With AK104 to Treatment Relapsed or Metastatic ESCC

Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou

Not yet recruiting

Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma

Lymphoma, Non-Hodgkin
The First People's Hospital of Changzhou

Not yet recruiting

Effect of Cytokine-induced Killer Cells for Advanced Malignant Gliomas

Cytokine-Induced Killer Cells | Advanced Milignant Gliomas
The First People's Hospital of Changzhou

Active, not recruiting

The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer

Colorectal Neoplasms
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Ovarian Carcinoma

Ovarian Carcinoma
The First People's Hospital of Changzhou

Active, not recruiting

Immunotherapy Combined With Capecitabine Versus Capecitabine Monotherapy in Advanced Breast Cancer

Breast Cancer
The First People's Hospital of Changzhou

Active, not recruiting

CIK in Treating Patients With Bladder Cancer

Urinary Bladder Neoplasms
The First People's Hospital of Changzhou

Not yet recruiting

Cytokine-induced Killer Study for Patients With Stage II Melanoma

Melanoma
The First People's Hospital of Changzhou

Not yet recruiting

Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas

Cytokine-Induced Killer Cells | Milignant Gliomas
The First People's Hospital of Changzhou

Not yet recruiting

CIK in Treating Patients With Esophageal Cancer

Esophageal Squamous Cell Carcinoma
The First People's Hospital of Changzhou

Not yet recruiting

DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating

Renal Neoplasma
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cholangiocarcinoma

Cholangiocarcinoma

China
The First People's Hospital of Changzhou

Completed

Microwave Ablation for Pulmonary Metastases From Colorectal Cancer

Colorectal Cancer
The First People's Hospital of Changzhou

Active, not recruiting

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for the Patients With Cervical Cancer

Cervical Cancer
The First People's Hospital of Changzhou

Active, not recruiting

Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer

Gastric Cancer
The First People's Hospital of Changzhou

Active, not recruiting

The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer

Stomach Neoplasms
The First People's Hospital of Changzhou

Completed

Hepatic RFA Increases T Cell Infiltraion and PD-L1 Expression in Primary Colorecatl Cancer

Colorectal Cancer
The First People's Hospital of Changzhou

Completed

TOF Versus SOX in Metastatic Gastric Cancer

Gastric Cancer
The First People's Hospital of Changzhou

Completed

Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer

Rectum Cancer
The First People's Hospital of Changzhou

Completed

Radiofrquency Ablation Combined With Cytokine-induced Killer Cells for Colorectal Cancer Liver Metastases

Colorectal Cancer

China
Red Cross Hospital, Hangzhou, China
First People's Hospital of Hangzhou; Sir Run Run Shaw Hospital; Zhejiang Provincial... and other collaborators

Unknown

Voriconazole for IPA in Chinese Patients With COPD (VIA-COPD)

COPD | Invasive Pulmonary Aspergillosis

China
The First People's Hospital of Changzhou

Unknown

SOX Versus XELOX for Patients With Peritoneal Metastasis of Colorectal Cancer

Colorectal Neoplasm

China
The First People's Hospital of Changzhou

Active, not recruiting

The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR

Adenocarcinoma of Lung
The First People's Hospital of Jingzhou

Recruiting

Early Arthroscopic Partial Meniscectomy(APM)

Meniscus Tear

China
The First People's Hospital of Jingzhou

Completed

Metabolic Syndrome and Degenerative Meniscus Lesions Related Knee Function

Metabolic Syndrome | Knee Arthritis | Obesity, Abdominal | Meniscus Lesion

China
The First People's Hospital of Jingzhou

Completed

Calorie Restricted Diet and Exercise

Metabolic Syndrome

China
The First People's Hospital of Jingzhou

Completed

Metabolic Syndrome and Degenerate Meniscus Tears

Metabolic Syndrome | Meniscus; Degeneration

China
The First People's Hospital of Jingzhou

Completed

Clinical Study on the Treatment of Hypertensive Intracerebral Hemorrhage With Panax Notoginseng Saponin (CSTHIHPNS)

Hematoma Absorption and Neurological Function Recovery
jiangjingting

Unknown

Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma

Lymphoma, B Cell

China
chenwu

Recruiting

Potential Clinical Utilities of Circulating Tumor DNA in Advanced HER2 Negative Gastric Cancer

Gastric Cancer | Circulating Tumor DNA (ctDNA)

China
Zhongnan Hospital
Shanxi Province Cancer Hospital; Ruijin Hospital; The First Affiliated Hospital... and other collaborators

Recruiting

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Acute Myeloid Leukaemia

China
Xiaonan Cui

Unknown

Clinical Trial on Acupuncture Therapy in Patients With Gastrointestinal Neoplasms Laparoscopic Surgery

Gastrointestinal Neoplasms

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Effect of Botulinum Toxin Injection Guided by Ultrasound Combined With Balloon Localization on Cricopharyngeal Achalasia

Dysphagia | Cricopharyngeal Achalasia

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Cortical Function Changes During Swallowing in Patients With Dysphagia in Lateral Medullary Syndrome

Deglutition Disorders | Lateral Medullary Syndrome

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC

Esophageal Cancer by AJCC V8 Stage

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Esophageal Arterial Infusion Chemotherapy Versus Systemic Intravenous Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Prospective, Multicentre, Randomised Controlled Clinical Study

Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University

Recruiting

Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer (AIPAAIAEC)

Esophageal Neoplasms

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome (GBS-PRAISING)

Guillain-Barre Syndrome

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 Blockade

Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell Carcinoma

Locally Advanced Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC

Stomach Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer

Esophageal Cancer

China
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCC

Esophageal Squamous Cell Carcinoma

China
The First Affiliated Hospital of Zhengzhou University

Recruiting

Survival Significance of Molecular Pathology and Genetic Variation in Brain Gliomas

Glioma | Molecular Sequence Variation | Genetic Change

China

Clinical Trials Sponsored by The First Hospital of Xiaoshan District, Hangzhou

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bosnia & Herzegovina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations